Whitaker Foundation Awards Aim To Inspire Innovation

The Whitaker Foundation, headquartered in Washington D.C., has presented 14 Special Opportunity Awards in biomedical engineering to teams of investigators who have come up with proposals to establish novel training programs in the field. The awards range from $250,000 to $750,000. The foundation recognizes that the field of bioengineering is a meeting place for many different disciplines. Medical sciences such as physiology and pha

Written byNeeraja Sankaran
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The Whitaker Foundation, headquartered in Washington D.C., has presented 14 Special Opportunity Awards in biomedical engineering to teams of investigators who have come up with proposals to establish novel training programs in the field. The awards range from $250,000 to $750,000.

The foundation recognizes that the field of bioengineering is a meeting place for many different disciplines. Medical sciences such as physiology and pharmacology; engineering subjects like mechanical and electrical engineering and computer science; and other areas of study, such as molecular biology, materials science, and mathematics, all have a hand in shaping the field.

Its influence is just as widespread, apparent in almost any facet of medicine, be it diagnosis (new imaging techniques that allow doctors to see inside the body without resorting to surgery), treatment (surgical lasers, artificial organs), or basic research (technologies like the polymerase chain reaction, or PCR; and molecular modeling of proteins).

The Whitaker Foundation ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies